Article info
PostScript
Correspondence
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?
- Correspondence to Johanne Lade-Keller, Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C DK-8000, Denmark; johanneromer{at}hotmail.com
Citation
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?
Publication history
- Received January 18, 2013
- Revised February 26, 2013
- Accepted February 27, 2013
- First published March 23, 2013.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions